Medical Research Council logo
MRC Experimental Medicine

Experimental Medicine Stage One

Supports United Kingdom experimental medicine teams through early-stage grants for mechanistic healthcare innovation.

Between cyclesMedical Research CouncilUnited Kingdom

The MRC Experimental Medicine programme funds researchers to investigate the causes, progression, and treatment of human disease through mechanistic studies in human participants. Projects must articulate a clear clinical challenge and involve experimental interventions or challenges of established safety β€” such as pharmacological, immunological, physiological, psychological, or infectious challen…

Human mechanistic research that investigates disease causes, progression, and treatment through experimental pharmacological, immunological, physiological, psychological, or infectious challenges of established safety.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.35 weeks
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.20%
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see the timeline

Guides for this application

All guides β†’
SPRIND (Bundesagentur fΓΌr Sprunginnovationen) logo
Open

SPRIND Recoding Medicine Challenge β€” Stage 1

πŸ‡©πŸ‡ͺSPRIND Β· Germany

Funds teams that curate a valuable health dataset and prove its worth with a working AI application.

BiotechMedtech+1
€480KOct'26
European Commission logo
Scheduled

Horizon Health: Bio-printing for Regenerative Medicine

πŸ‡ͺπŸ‡ΊEuropean Commission Β· European Union

Funds €7–10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.

BiotechMedtech
€7M – €10MSep'27
Biotechnology and Biological Sciences Research Council logo
Open

BBSRC Stand-alone LINK β€” Always Open

πŸ‡¬πŸ‡§BBSRC Β· United Kingdom

Supports United Kingdom university and industry teams through LINK grants that share innovation ownership and risk.

BiotechAgritech+4
Β£2M
Multiple Sclerosis Society UK logo
Open

MS Society Skills Development Awards

πŸ‡¬πŸ‡§MS Society UK Β· United Kingdom

Provides short grants for early career researchers building advanced multiple sclerosis skills in the United Kingdom.

BiotechMedtech+1
Β£2K
European Commission logo
Scheduled

Novel Small-Molecule Antivirals for Epidemic-Potential Pathogens

πŸ‡ͺπŸ‡ΊEuropean Commission Β· European Union

Funds small-molecule antivirals that expand preparedness and treatment options for future viral epidemics and pandemics.

BiotechMedtech
€9M – €11MApr'27
European Commission logo
Scheduled

Personalised approaches to reduce risks from adverse drug reactions due to multiple medications

πŸ‡ͺπŸ‡ΊEuropean Commission Β· European Union

Funds safer medication management using biomarkers, clinical data and decision support.

MedtechBiotech+1
€8M – €10MApr'27